查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1961320

正子斷層掃描市場－全球產業規模、佔有率、趨勢、機會、預測：按產品類型、應用、最終用戶、地區和競爭對手分類，2021-2031年

Positron Emission Tomography Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球正子斷層掃描（PET）市場預計將從 2025 年的 31.2 億美元成長到 2031 年的 46.8 億美元，複合年成長率為 6.99%。

正子斷層掃描（PET）是一種利用放射性示蹤劑測量代謝過程的功能性影像技術，能夠對複雜的病理狀況進行精確診斷和後續觀察。市場成長的主要驅動力是慢性病（尤其是腫瘤和心臟病）發病率的上升，這推動了對高精度早期檢測工具的需求。此外，PET/CT和PET/MRI等混合系統的日益普及提高了診斷準確性和工作流程效率，加速了該技術在全球範圍內的推廣應用。

市場概覽
預測期 2027-2031
市場規模：2025年 31.2億美元
市場規模：2031年 46.8億美元
複合年成長率：2026-2031年 6.99%
成長最快的細分市場 腫瘤學
最大的市場 北美洲

另一方面，複雜的物流和醫用放射性同位素的間歇性短缺對市場擴張構成重大障礙，並導致供應鏈脆弱。這些對時間要求極高的物質的生產依賴於數量有限的核子反應爐，也成為穩定提供服務的瓶頸。世界核能協會在2024年發布的報告凸顯了該領域的巨大規模和這些診斷方法的關鍵作用，報告顯示，全球約有5000萬例核醫學檢查，證實了現代醫學依賴這些先進技術。

市場促進因素

全球癌症負擔日益加重是正子斷層掃描（PET）市場擴張的主要驅動力。癌症病例的增加提高了對精準分期、重新評估和療效評估的需求，直接導致PET掃描次數的增加。這些掃描對於檢測先於解剖結構變化的代謝變化至關重要，從而能夠進行適當的治療性介入。美國癌症協會發布的《2024年癌症事實與數據》報告也印證了這一成長趨勢，該報告預測僅在美國每年就將新增2,001,140例癌症病例，確保了整個治療過程中對影像服務持續的需求。

同時，用於治療神經系統疾病（尤其是阿茲海默症）的新型放射性示蹤劑的研發，是推動二級市場成長的強勁動力。放射性藥物的創新使得澱粉樣斑塊和Tau蛋白纖維的可視化成為可能，從而拓展了PET在老年醫學和神經病學領域的效用，以應對失智症障礙。根據阿茲海默症協會2024年3月發布的報告，約有690萬65歲及以上的美國人患有老年失智症症，這是一個龐大的患者群體。這些藥物的商業性成功也體現在Lantheus公司2023年全年13億美元的全球銷售額上，反映出先進顯影劑的強勁市場接受度。

市場挑戰

複雜的物流系統和醫用放射性同位素的間歇性供不應求是全球正子斷層掃描（PET）市場發展的主要障礙。該行業依賴脆弱的供應鏈，關鍵示踪劑的生產集中在有限的設施和老舊的核子反應爐中。一旦這些關鍵基礎設施面臨意外維護或停機，就會立即出現瓶頸，擾亂全球醫療保健系統。因此，醫療機構難以維持穩定的工作安排，導致檢查取消，並且除非能夠保證可靠的示踪劑供應，否則不願投資新的PET設備。

由於這些快速崩壞的材料需要即時供應，有效儲備受到阻礙，這種脆弱性進一步加劇。供應不穩定會削弱市場信心，阻礙營運能力，並妨礙診斷能力的充分利用。正如《歐洲核子醫學》雜誌在2024年指出的那樣，歐洲市場佔全球診斷同位素消耗量的20%以上，凸顯了大量患者極易受到生產網路中斷的影響。這種供應不穩定將限制先進檢測方法的應用，並最終減緩整體市場成長。

市場趨勢

將人工智慧 (AI) 整合到影像重建中，從根本上改變了 PET 系統的功能。製造商正在利用深度學習演算法來提高信噪比，從而在減少放射性示踪劑用量和縮短掃描時間的同時，實現高品質成像。這項技術變革平衡了影像清晰度和病患輻射暴露，使得檢測以前無法發現的病灶成為可能。美國食品藥物管理局(FDA) 在 2024 年 8 月發布的報告也印證了這一趨勢：在已通過核准的AI/機器學習醫療設備中，79% 為放射科設備，凸顯了這些軟體增強功能獲得了重要的監管核准。

同時，用於治療和診斷的放射性藥物的成長正在促成診斷性PET成像與標靶治療之間的直接商業性合作。這種方法將基於診斷性同位素和基因組標靶的治療藥物相結合，需要在治療前進行PET掃描以確認標靶表達。這確保了只有預期獲益的患者才能接受治療，並將掃描確立為高價值療法的先決條件。根據諾華公司截至2024年7月的會計年度財務報告，其放射性配體療法「Pluvicto」的銷售額達到3.45億美元（經外匯調整後成長44%），這必然導致對PSMA-PET成像的需求增加。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球正子斷層掃描市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品類型（全環PET掃描器、部分環PET掃描器）
    • 依應用領域（腫瘤科、心臟科、神經科等）
    • 依最終使用者（醫院、診斷中心、研究機構等）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美正子斷層掃描市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲正子斷層掃描市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區正子斷層掃描市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲正子斷層掃描市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲正子斷層掃描市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球正子斷層掃描市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • GE HealthCare Technologies Inc.
  • Toshiba Corporation
  • Koninklijke Philips NV
  • Siemens Healthineers AG
  • Hitachi Medical Corporation
  • Positron Corporation
  • Mediso Ltd.
  • Yangzhou Kindsway Biotech Co., Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23761

The Global Positron Emission Tomography Market is projected to expand from USD 3.12 Billion in 2025 to USD 4.68 Billion by 2031, registering a CAGR of 6.99%. As a functional imaging modality using radiotracers to measure metabolic processes, PET enables the precise diagnosis and monitoring of complex medical conditions. Market growth is primarily driven by the rising prevalence of chronic diseases, especially within oncology and cardiology, creating a need for high-precision early detection tools. Furthermore, the increasing adoption of hybrid systems like PET/CT and PET/MRI is enhancing diagnostic accuracy and workflow efficiency, boosting technology uptake globally.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 3.12 Billion
Market Size 2031USD 4.68 Billion
CAGR 2026-20316.99%
Fastest Growing SegmentOncology
Largest MarketNorth America

Conversely, market expansion faces significant hurdles due to complex logistics and sporadic shortages of medical radioisotopes, which cause supply chain vulnerabilities. The dependence on a limited number of production reactors for these time-sensitive materials creates bottlenecks for consistent service delivery. Highlighting the sector's vast scale and the critical role of these diagnostics, the World Nuclear Association reported in 2024 that approximately 50 million nuclear medicine procedures were performed globally, underscoring modern healthcare's reliance on these advanced capabilities.

Market Driver

The rising global burden of cancer acts as the primary catalyst expanding the Positron Emission Tomography landscape. Increasing oncological cases necessitate precise staging, restaging, and treatment response evaluation, directly boosting PET scan volumes. These procedures are vital for detecting metabolic changes prior to anatomical alterations, facilitating appropriate therapeutic interventions. Emphasizing this growing burden, the American Cancer Society's 'Cancer Facts & Figures 2024' report projected 2,001,140 new cancer cases in the United States alone for the year, ensuring sustained demand for imaging services throughout the care continuum.

Concurrently, the development of novel radiotracers for neurological conditions, specifically Alzheimer's disease, is a strong secondary market driver. Innovations in radiopharmaceuticals allow for the visualization of amyloid plaques and tau tangles, extending PET utility to geriatric and neurology sectors to address cognitive disorders. According to the Alzheimer's Association's March 2024 report, an estimated 6.9 million Americans aged 65 and older are living with Alzheimer's dementia, representing a significant patient base. The commercial success of these agents is illustrated by Lantheus, which reported worldwide revenue of $1.3 billion for the full year 2023, reflecting strong financial adoption of advanced imaging agents.

Market Challenge

The complex logistics and intermittent shortages of medical radioisotopes represent a significant barrier to the Global Positron Emission Tomography Market. The sector depends on a fragile supply chain where essential tracer production is concentrated in limited facilities and aging nuclear reactors. When these key infrastructure points experience unplanned maintenance or shutdowns, it causes immediate bottlenecks that disrupt the global healthcare system. Consequently, facilities struggle to maintain consistent schedules, leading to cancellations and hesitation to invest in new PET modalities without assured tracer availability.

This vulnerability is worsened by the just-in-time nature of these rapidly decaying materials, which prevents effective stockpiling. The lack of a stable supply undermines market confidence and hampers operational throughput, preventing full utilization of diagnostic capabilities. As noted by Nuclear Medicine Europe in 2024, the European market accounted for over 20% of global diagnostic isotope consumption, highlighting the massive volume of patients vulnerable to production network disruptions. Such supply insecurity restricts the broader adoption of advanced procedures, ultimately slowing the market's overall growth.

Market Trends

Artificial intelligence integration in image reconstruction is fundamentally transforming PET system capabilities. Manufacturers are utilizing deep learning algorithms to improve signal-to-noise ratios, facilitating high-quality imaging with reduced radiotracer doses and shorter scan times. This technological shift balances image clarity with patient exposure, enabling the detection of previously invisible lesions. Validating this trend, the U.S. Food and Drug Administration reported in August 2024 that radiology devices comprised 79% of all authorized AI/ML-enabled medical devices, highlighting the significant regulatory clearance of these software enhancements.

Simultaneously, the growth of theranostic radiopharmaceuticals is creating a direct commercial link between diagnostic PET imaging and targeted therapy. This method pairs a diagnostic isotope with a therapeutic agent based on genomic targets, requiring a PET scan to confirm target expression before treatment. This ensures therapy is reserved for patients who will benefit, making the scan a prerequisite for high-value treatments. According to Novartis' July 2024 financial report, sales for the radioligand therapy Pluvicto reached $345 million, a 44% increase in constant currency, driving requisite demand for companion PSMA-PET imaging.

Key Market Players

  • GE HealthCare Technologies Inc.
  • Toshiba Corporation
  • Koninklijke Philips N.V.
  • Siemens Healthineers AG
  • Hitachi Medical Corporation
  • Positron Corporation
  • Mediso Ltd.
  • Yangzhou Kindsway Biotech Co., Ltd.

Report Scope

In this report, the Global Positron Emission Tomography Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Positron Emission Tomography Market, By Product Type

  • Full Ring PET Scanner
  • Partial Ring PET Scanner

Positron Emission Tomography Market, By Application

  • Oncology
  • Cardiology
  • Neurology
  • Others

Positron Emission Tomography Market, By End User

  • Hospitals
  • Diagnostic Centres
  • Research Institutes
  • others

Positron Emission Tomography Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Positron Emission Tomography Market.

Available Customizations:

Global Positron Emission Tomography Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Positron Emission Tomography Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Full Ring PET Scanner, Partial Ring PET Scanner)
    • 5.2.2. By Application (Oncology, Cardiology, Neurology, Others)
    • 5.2.3. By End User (Hospitals, Diagnostic Centres, Research Institutes, others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Positron Emission Tomography Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Positron Emission Tomography Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Positron Emission Tomography Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Positron Emission Tomography Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Positron Emission Tomography Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Positron Emission Tomography Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. France Positron Emission Tomography Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Positron Emission Tomography Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Positron Emission Tomography Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Positron Emission Tomography Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia Pacific Positron Emission Tomography Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Positron Emission Tomography Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Positron Emission Tomography Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Positron Emission Tomography Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Positron Emission Tomography Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Positron Emission Tomography Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Middle East & Africa Positron Emission Tomography Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Positron Emission Tomography Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Positron Emission Tomography Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Positron Emission Tomography Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. South America Positron Emission Tomography Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Positron Emission Tomography Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Positron Emission Tomography Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Positron Emission Tomography Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Positron Emission Tomography Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. GE HealthCare Technologies Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Toshiba Corporation
  • 15.3. Koninklijke Philips N.V.
  • 15.4. Siemens Healthineers AG
  • 15.5. Hitachi Medical Corporation
  • 15.6. Positron Corporation
  • 15.7. Mediso Ltd.
  • 15.8. Yangzhou Kindsway Biotech Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer